Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Nature Communications|January 10, 2024
Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.Signal Transduction and Targeted Therapy|January 16, 2026
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterationsPhilipp Hafner, Steffen J Keller, Xun Chen, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Prostaglandin E 2 controls the metabolic adaptation of T cells to the intestinal microenvironmentMatteo Villa, David E Sanin, Petya Apostolova, et al.Cancer Research|November 21, 2025
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancerRajendra Kumar, Sheila Jonnatan, David E Sanin, et al.British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.The Journal of Experimental Medicine|July 8, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHDSangya Chatterjee, Tamina Rückert, Ina Martin, et al.Nature Immunology|February 2, 2023
Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and functionJoy Edwards-Hicks, Petya Apostolova, Joerg M Buescher, et al.Blood|July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulationJenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.Pageof 5